Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Immunomodulatory properties of farnesoids: The new steroids?
[Recurring neuromyelitis without optic neuritis: a case report].
Vitamin B12 deficiency mimicking NMO spectrum disorder.
Neuroendocrine Immunoregulation in Multiple Sclerosis.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.
Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
Aging and multiple sclerosis.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
History, applications, and mechanisms of deep brain stimulation.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Acute exacerbation of multiple sclerosis presenting with facial metamorphopsia and palinopsia.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
Multiple sclerosis: On the TRAIL of IFN-β response.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Pages
« first
‹ previous
…
242
243
244
245
246
247
248
249
250
…
next ›
last »